Bacterial Vaginosis Market Size in 7MM is expected to witness a major change in the study period 2019-2032 | Key Companies- DARÉ BIOSCIENCE, Osel, and Others

The Bacterial Vaginosis market report provides current treatment practices, Bacterial Vaginosis emerging drugs, Bacterial Vaginosis market share of the individual therapies, current and forecasted epidemiology in 7MM covering the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan from 2019 to 2032. Bacterial Vaginosis Pipeline analysis across different stages of development (Phase III and Phase II), different emerging trends, and comparative analysis of pipeline products with detailed clinical profiles, key cross-competition, launch date along with product development activities.

Recent Developmental Activities in the Bacterial Vaginosis Treatment Landscape

• Secnidazole is not a very new drug class, it date back to the late 1960s, yet many US healthcare providers were unaware of its existence. Most recent to the US market is Solosec (secnidazole) which was approved in2017. Secnidazole is FDA approved only for BV at present. The first approved therapy in the US, Solosecwas designated as a Qualified Infectious Disease Product (QIDP)for the treatment of BV by FDA and granted it Fast Track designation.

• In December, 2021, Daré announced that the US FDA approved XACIATO™(clindamycin phosphate) vaginal gel, 2% (formerly known as DARE-BV1)for the treatment of bacterial vaginosis in females 12 years of age and older. In March 31,2022, Organon and Daré Bioscience, Inc. announced that they have entered into an agreement whereby Organon will license global rights to XACIATO™ (clindamycinphosphate) vaginal gel, 2%.

Explore more information about the Latest Drugs Launch, New Breakthroughs of Drugs or Therapies Approach, Treatment Practices, and Forecasted Epidemiology @ Bacterial Vaginosis Market Size Report- https://www.delveinsight.com/sample-request/bacterial-vaginosis-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr

Bacterial Vaginosis Overview
Bacterial Vaginosis (BV) also referred to as nonspecific vaginitis, is a vaginal condition that can produce vaginal discharge and results from an overgrowth of certain kinds of bacteria in the vagina. Bacterial vaginosis is the most common infectious vaginitis. Bacterial vaginosis appears to increase the risk of pelvic inflammatory disease, post abortion and postpartumendometritis, and posthysterectomy vaginal cuff infection. In pregnancy, bacterial vaginosis is associated with an increased risk of chorioamnionitis, premature rupture of membranes, preterm labor, and preterm birth.

Key Takeaways from the Bacterial Vaginosis Market

• The expected launch of therapies and the increasing prevalence will lead to market growth during the forecast period (2023-2032).

• The Bacterial Vaginosis Companies include DARÉ BIOSCIENCE, Osel, and Others

• Promising Bacteria Vaginosis Pipeline Therapies include LACTIN-V, XACIATO, and Others

Bacteria Vaginosis Epidemiology Segmentation in the 7MM

• Bacteria Vaginosis Prevalent Cases
• Bacteria Vaginosis Age-Specific Prevalent Cases
• Bacteria Vaginosis Diagnosed Prevalent Cases
• Bacteria Vaginosis Treatable Cases

Download the report to understand which factors are driving Bacteria Vaginosis epidemiology trends @ Bacteria Vaginosis Epidemiological Insights- https://www.delveinsight.com/sample-request/bacterial-vaginosis-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr

Bacteria Vaginosis Treatment Market
The major treatment options of Bacterial Vaginosis are metronidazole, clindamycin oral or vaginal suppositories, and metronidazole vaginal gel. Although up to 30% of BV cases may resolve without treatment, this condition can also be treated with either clindamycin or metronidazole. Both of these medications are effective if taken by mouth or applied vaginally. Additionally, both are safe to be used by pregnant women.

Bacteria Vaginosis Market Dynamics
The dynamics of Bacterial Vaginosis treatment market is anticipated to change during the forecast period as companies across the 7MM are diligently working towards the development of novel treatment option to combat the existing treatment based unmet needs. Key players, such as Dare Biosciences, Osel, Gedea Biotech and other companies are involved in developing potential agents for the treatment of Bacteria Vaginosis.

Learn more about the FDA-approved drugs for Bacteria Vaginosis @ Bacteria Vaginosis Market Drivers and Barriers- https://www.delveinsight.com/sample-request/bacterial-vaginosis-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr

Scope of the Bacteria Vaginosis Market Report

• Coverage- 7MM

• Bacteria Vaginosis Companies- DARÉ BIOSCIENCE, Osel, and Others

• Bacteria Vaginosis Pipeline Therapies- LACTIN-V, XACIATO, and Others

• Bacteria Vaginosis Market Dynamics: Bacteria Vaginosis Market Drivers and Barriers

• Bacteria Vaginosis Market Access and Reimbursement, Unmet Needs, and Emerging Drugs

Discover more about Bacteria Vaginosis Drugs in development @ Bacteria Vaginosis Emerging Drugs and Companies- https://www.delveinsight.com/sample-request/bacterial-vaginosis-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr

Table of Content
1. Key Insights
2. Executive Summary of Bacterial Vaginosis
3. Competitive Intelligence Analysis for Bacterial Vaginosis
4. Bacterial Vaginosis: Market Overview at a Glance
5. Bacterial Vaginosis: Disease Background and Overview
6. Patient Journey
7. Bacterial Vaginosis Epidemiology and Patient Population
8. Treatment Algorithm, Current Treatment, and Medical Practices
9. Bacterial Vaginosis Unmet Needs
10. Key Endpoints of Bacterial Vaginosis Treatment
11. Bacterial Vaginosis Marketed Products
12. Bacterial Vaginosis Emerging Therapies
13. Bacterial Vaginosis: Seven Major Market Analysis
14. Attribute analysis
15. 7MM: Market Outlook
16. Access and Reimbursement Overview of Bacterial Vaginosis
17. KOL Views
18. Market Drivers
19. Market Barriers
20. Appendix
21. DelveInsight Capabilities
22. Disclaimer
23. About DelveInsight

Got Queries? Reach out for more information about the Patient Population, Treatment Algorithm, Unmet Needs, and Emerging Drugs of the report @ Bacterial Vaginosis Market Dynamics Report- https://www.delveinsight.com/sample-request/bacterial-vaginosis-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr

About Us

DelveInsight is a Business Consulting and Market research company, providing expert business solutions for life science vertical and offering quintessential advisory services in the areas of R&D, Strategy Formulation, Operations, Competitive Intelligence, Competitive Landscaping, and Mergers & Acquisitions.

Contact Us

Yash Bhardwaj

info@delveinsight.com

This release was published on openPR.